EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cancer cell death induced by the NAD antimetabolite Vacor discloses the antitumor potential of SARM1

Giuseppe Ranieri, Andrea Lapucci, Giuseppe Orsomando, Nadia Raffaelli, Alberto Chiarugi, Daniela Buonvicino iD

FEBS Letters · 2025

DOI: 10.1002/1873-3468.70169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Letters, 2025. Verfasst von Giuseppe Ranieri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Italy. Hauptthemen laut MEDLINE: Armadillo Domain Proteins, Cytoskeletal Proteins, NAD. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AIRC and Fondazione CR Firenze under IG 2017.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In a previous study, we showed that the NAD antimetabolite Vacor is metabolized by two enzymes implicated in the NAD salvage pathway—to Vacor mononucleotide (VMN) by nicotinamide phosphoribosyltransferase (NAMPT) and, in turn, to Vacor adenine dinucleotide (VAD) by nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2)—leading to NAD depletion and antitumor activity. Recent findings in neurons show that VMN activates SARM1, a NAD glycohydrolase, triggering NAD depletion and degeneration. In this study, we report that altering NMNAT2 levels did not affect Vacor‐induced NAD depletion or cell death. In contrast, SARM1 expression alone was sufficient to induce Vacor sensitivity. Further, we report that cancer cells sense the abnormal expression of SARM1 and readily induce the expression of NMNAT2. Overall, the data underscore the antitumor potential of pharmacological approaches aimed at activating SARM1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Armadillo Domain ProteinsCytoskeletal ProteinsNADHumansNicotinamide-Nucleotide AdenylyltransferaseCell Line, TumorCell Death

Stichwörter der Autor:innen

NMNAT2SARM1Vacorcancer cells

Substanzen

Armadillo Domain ProteinsCytoskeletal ProteinsNicotinamide-Nucleotide AdenylyltransferaseSARM1 protein, humanNADNMNAT2 protein, human

Autor:innen und Institutionen

  • Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Italy.
  • Department of Clinical Sciences (DISCO), Section of Biochemistry, Polytechnic University of Marche, Ancona, Italy.
  • Department of Agricultural, Food and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy.

ORCID-Profile: Daniela Buonvicino

Förderung

  • AIRC and Fondazione CR Firenze under IG 2017

Zitieren

APA

Ranieri, G., Lapucci, A., Orsomando, G., Raffaelli, N., Chiarugi, A., & Buonvicino, D. (2025). Cancer cell death induced by the NAD antimetabolite Vacor discloses the antitumor potential of SARM1. FEBS Letters. https://doi.org/10.1002/1873-3468.70169

Vancouver

Ranieri G, Lapucci A, Orsomando G, Raffaelli N, Chiarugi A, Buonvicino D. Cancer cell death induced by the NAD antimetabolite Vacor discloses the antitumor potential of SARM1. FEBS Letters. 2025. doi:10.1002/1873-3468.70169

BibTeX
@article{Ranieri2025,
  author = {Ranieri, Giuseppe and Lapucci, Andrea and Orsomando, Giuseppe and Raffaelli, Nadia and Chiarugi, Alberto and Buonvicino, Daniela},
  title = {Cancer cell death induced by the NAD antimetabolite Vacor discloses the antitumor potential of SARM1},
  journal = {FEBS Letters},
  year = {2025},
  doi = {10.1002/1873-3468.70169}
}
Kostenlos starten →